Malaria Ag Rapid Testing Market Overview
According to the latest research by Future Market Insights, Malaria Ag rapid Testing Market is set to experience 5% growth during the year 2021-2031.
Malaria Ag rapid testing kits allows for quick detection of malarial antigen present in human body without the use of microscopes or in lab set-ups.
Primary advantage of using a rapid testing kit is its ease of collection, cost effectiveness, safety and user friendly.
What is Driving the Demand for Malaria Ag Rapid Testing Market
Malaria Ag rapid testing or rapid diagnostic test are lateral flow immunochromatographic antigen detection test, usually available in test strip or cassette form. These test detect the presence of malarial parasite antigen, in an infected human blood giving results within 15 minutes. Such procedures are simple, safe and easier for quick diagnosis of malaria at an initial stage and does not require special equipment or training.
An increasing number of cases of malaria in tropical countries along with increasing travelers visiting these countries, and in turn getting infected by malaria, can be seen rising in recent years.
Also the unavailability of lab testing for diagnosis of malaria in most endemic countries has further increased the necessity for the malaria antigen rapid tests.
For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-13904
A per the 2019-20 report by World Health Organization (WHO), an estimated 229 Mn cases of malaria was found globally in 87 malaria-endemic countries in 2019.
Of which, 05 countries in Africa region namely, Nigeria (27%), the Democratic Republic of the Congo (12%), Uganda (5%), Mozambique (4%) and Niger (3%), accounted for about 51% of the global cases.
Thus, the demand for the Malaria Ag rapid testing market is likely to provide incremental opportunity in the forecasted period.
Which Factors are likely to Augment the Growth of the Malaria Ag Rapid Testing Market
The field of malaria Ag rapid testing market is witnessing series of advancements and is further expected to offer effective diagnostic solutions for infections caused by malaria.
An increasing number of deaths caused due to non-diagnosis of malaria at early stages and increased resistance of parasite especially
P.falciparum to anti-malarial drugs has increased the need for these rapid diagnostic tests to diagnose the disease at the earliest and provide for treatment of same.
As per the 2019-20 report by World Health Organization (WHO), 67% (274,000) of the total deaths caused by malaria, at global level, consisted of children below 5 years of age, in 2019.
For any queries linked with the report, ask an analyst >> https://www.futuremarketinsights.com/ask-question/rep-gb-13904
Investment in malaria programs and research & development for malaria control and elimination are being undertaken by government and industry players in various regions. Various Public and private sector organizations are also playing major role in promoting and supporting the clinical development of key products.
A per the 2019-20 report by World Health Organization (WHO), an estimated US$ 3 Bn was the total funding provided for malaria control and elimination.
Out of this total, US$ 900 Mn (31% of total funds) of funding was contributed by the government of endemic countries.
It is thus, expected for the malaria Ag rapid test market to seek a growth in the forecasted period.
North America Malaria Ag Rapid Testing Market Outlook
North America market growth is largely driven by the prevalence of “Airport” Malaria, a common term referring to the malarial infection caused due to the travelling population. Those who visit the malaria-endemic countries and in return get themselves exposed to the infection, resulting in transmission of the infection to the non-infected ones.
As per Centers for Disease Control and Prevention (CDC) report in 2019, approximately 2000 cases of malaria are detected every year in United States.
This is majorly due to increasing number of returning travelers and immigrants coming from countries where malaria transmission happened such as Sub Saharan Africa and South Asia.
Early detection of such cases can reduce future complications as well as risk of transmission associated with the infection. The FDA approved BinaxNOW rapid diagnostic test kit can test for malaria in an individual and help confirm the result.
Alternatively, various policy developments, scientific researches and initiatives, mosquito control programs undertaken by government to eliminate and to reduce the malaria transmission in this segment are expected to further improve the market scenario of Malaria Ag rapid testing.
Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-13904
With increasing number of malaria cases, it is believed to promote the growth of the malaria rapid testing market in the forecasted period.
Europe Demand Outlook for Malaria Ag rapid testing
Europe is anticipated to be the largest market for Malaria Ag rapid testing.
The continuous increase in business related/leisure travels, or migratory movements for employment to and from endemic countries have increased the chances of importing malaria to a malaria-free or non-endemic countries.
As per European Centre for Disease Prevention and Control (ECDC) Annual epidemiological report in 2019, 8641 cases of malarial were reported in Europe region, of which 99% of the cases were confirmed to be travel related infected malaria cases, while the rest 1% was acquired in the Europe.
A trend was observed in travel – related cases when the number of infections increase during or immediately after summer holidays (July –September).
The continuous efforts of government and private players in increasing the awareness about the control and management of malarial cases, growing research and development activities to diagnose malarial causing species in the European region which will further facilitate the growth of the market in the forecasted period.
Who are the key Manufacturers and Suppliers of the Malaria Ag Rapid Testing
Some of the key players of Malaria Ag rapid testing include
- Abbott
- Accuquik™ Test Kits (USA) Advy Chemical Pvt. Ltd.
- Arkray Healthcare Pvt Ltd
- CTK Biotech Inc.
- Biotrol laboratories Pvt. Ltd.
- malarex Limited (UK)
- Alere
- Ameritek Inc.
- Apacor ltd.
- Atmo Diagnostics
- Biosynex
- Boson Biotech Co. Ltd.
- HWTAi BioTec
- Nectar Lifesciences
- standard Diagnostics
- TCS Biosciences Ltd
- Teco Diagnostics
- okchem.com Bio Lab Diagnostics (I) Private Limited
- China Tianjin Recare Co., Ltd
- Avecon Healthcare Pvt Ltd.
Companies offering Malaria Ag rapid testing are involved in existing product upgrades, new product launches, mergers and collaborations to enhance their market position.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain.
The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments.
The report also maps the qualitative impact of various market factors on market segments and geographies.
For critical insights, request for PDF Brochure https://www.futuremarketinsights.com/reports/brochure/rep-gb-13904
Malaria Ag Rapid Testing Market Report Highlights:
- Detailed overview of parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
NOTE – All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of the company
Key Segments
By Product Type:
- Test Strip
- Cassette
By Distribution Channel:
- Drugstore
- Retail Pharmacy
- Hospital Chain Pharmacy
- Online Pharmacy
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa
About FMI:
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact Us:
Mr. Debashish Roy
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
MARKET ACCESS DMCC Initiative
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com